c
x
chart
exchange
Terminal
Flow
Screener
Markets
Trends
Premium
Alerts
EST
UTC-5 New York
Blue Chip
Log in
Sign up
Wedbush cuts Foghorn Therapeutics stock rating on drug setback
Investing.com | Oct 2, 2026 7:42 AM EDT
Read original article